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Objectives  
• Identify what is the modification and which technique is used to 
obtain rapid growth to achieve market size.  
 
• Existence of protocols and control strategies for AquAdvantage 
salmon production. 
 
• Risks associated with the product and if it is safe for human 
consumption. 
Introduction 
AquAdvantage Salmon is a genetically modified organism 
developed by AquBounty Technologies.  
The objective of this transgenic organism is to increase the growth 
rate to obtain the same of conventional salmon faster.  
Conclusions  
• Expressing growth hormone controlled by 
promoter opAFP (opAFP-GHc2) in Atlantic salmon 
reached rapid growth. We introduce growth hormone 
gene from a Pacific salmon and a promoter from a 
Zoarces americanus to the genome Atlantic salmon. 
These genes enable it to grow all year instead of only 
during warm months. 
 
• There are established measures to reduce risk 
environmental impact if any of these organisms 
escape from their facilities. The control measures to 
keep all production under control are: physical, 
geographical and biological. 
 
• It is early to affirm that consumption of modified 
salmon is safe, because there are still many aspects 
unclear and need further investigations to decide 
approve or not this product. 
 
Figure 2.  Differences in growth between AquAdvantage Salmon and 
conventional during the first three years of life 
(http://singlebarbed.com/2009/02/). 
Figure 3. Physical description  of the cassette that we insert into genome  of  Atlantic 
salmon  using a plasmid. Confirmation technique to determine  presence or absence of 
construct opAFP-GHc2 (Anonymous, 2012). 
Figure 1.  Differences in growth between AquAdvantage Salmon and 
conventional during the first three years of life 
(http://aquabounty.com/). 
Personal view  
In my point of view, AquAdvantage Salmon should be evaluated for possible acceptance as a product for human consumption in a few 
years, when they  have enough evidence about safety by the consumer. It is necessary more investigation about effects than can 
produce opAFP-GHc2 in human genome (dose, activity levels of growth hormone, etc.).  On the other hand, I think if we continue 
studying this GMO  can be an interesting product for our society.  
 
